A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel
In the review based on existing clinical recommendations and guidelines of the European cardiology society and results of clinical and register trials difficult questions about a antithrombotic therapy in the patients with an acute coronary syndrome and percutaneous coronary interventions were discu...
Main Authors: | V. V. Kashtalap, O. L. Barbarash |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/3768 |
Similar Items
-
Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations
by: V. V. Kashtalap, et al.
Published: (2019-04-01) -
ACTUAL PROBLEMS OF ANTITOMBOTIC THERAPY IN ACUTE CORONARY SYNDROME (FOLLOWING THE MATERIAL PRESENTED AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2017)
by: V. V. Kashtalap, et al.
Published: (2017-11-01) -
Clopidogrel therapy effects on cell hemostasis in acute coronary syndrome
by: R. A. Rakhimova, et al.
Published: (2008-12-01) -
Risk Stratification after an Acute Coronary Syndrome: Significance of Antithrombotic Therapy
by: Victoria A. Brazhnik, et al.
Published: (2021-04-01) -
THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01)